Search Results - "Janicot, Michel"
-
1
First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
Published in PloS one (30-11-2017)“…To evaluate the safety and tolerability of intravitreal ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2…”
Get full text
Journal Article -
2
JNJ-26481585, a Novel “Second-Generation” Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity
Published in Clinical cancer research (15-11-2009)“…Purpose: Histone deacetylase (HDAC) inhibitors have shown promising clinical activity in the treatment of hematologic malignancies, but their activity in solid…”
Get full text
Journal Article -
3
Safety evaluation of long-term temperature controlled whole-body thermal treatment in female Aachen minipig
Published in International journal of hyperthermia (01-01-2021)“…Objective: Thermal treatment (TT), defined as treatment using supra-physiological body temperatures (39-45 C), somewhat resembles fever in terms of temperature…”
Get full text
Journal Article -
4
Biological Role and Therapeutic Targeting of TGF-β3 in Glioblastoma
Published in Molecular cancer therapeutics (01-06-2017)“…Abstract Transforming growth factor (TGF)-β contributes to the malignant phenotype of glioblastoma by promoting invasiveness and angiogenesis and creating an…”
Get full text
Journal Article -
5
Transcriptome-wide analysis reveals insight into tumor suppressor functions of 1B3, a novel synthetic miR-193a-3p mimic
Published in Molecular therapy. Nucleic acids (05-03-2021)“…Emerging data show that microRNA 193a-3p (miR-193a-3p) has a suppressive role in many cancers and is often downregulated in tumors, as compared to surrounding…”
Get full text
Journal Article -
6
The tumor suppressor 5A2, a synthetic miR-7-5p mimic, targets oncogenic and metabolic pathways, as revealed by transcriptome-wide analysis
Published in Frontiers in drug discovery (07-07-2023)“…As cancer is a multifactorial disease, the multimodal action of microRNAs makes them an attractive tool for novel therapeutic approaches. The tumor suppressive…”
Get full text
Journal Article -
7
Disruption of Murine Mus81 Increases Genomic Instability and DNA Damage Sensitivity but Does Not Promote Tumorigenesis
Published in Molecular and Cellular Biology (01-09-2005)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
8
Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth
Published in Molecular biology of the cell (01-12-2005)“…Early cellular events associated with tumorigenesis often include loss of cell cycle checkpoints or alteration in growth signaling pathways. Identification of…”
Get full text
Journal Article -
9
P422: TARGETING THE WT1MUT‐MIR‐193A TRANSCRIPTIONAL AXIS WITH INT‐1B3, A NOVEL LIPID NANOPARTICLE‐FORMULATED MIR‐193A‐3P MIMIC IN ACUTE MYELOID LEUKEMIA
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
10
Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles
Published in Cancer biology & therapy (01-07-2004)“…Short nucleic acid sequences specific to oncogene targets such as bcl-2, bcr-abl, and c-myc have been shown to exhibit specific anti-cancer activity in vitro…”
Get full text
Journal Article -
11
Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasome-mediated degradation of survivin
Published in The Journal of pharmacology and experimental therapeutics (01-02-2003)“…The naturally occurring cyclic tetrapeptide chlamydocin is a very potent inhibitor of cell proliferation. Here we show that chlamydocin is a highly potent…”
Get more information
Journal Article -
12
Therapeutic Targeting of TGFβ Ligands in Glioblastoma Using Novel Antisense Oligonucleotides Reduces the Growth of Experimental Gliomas
Published in Clinical cancer research (01-12-2019)“…Transforming growth factor (TGF)-β is expressed at high levels by glioma cells and contributes to the malignant phenotype of glioblastoma. However, its…”
Get full text
Journal Article -
13
Real-time gene expression analysis in human xenografts for evaluation of histone deacetylase inhibitors
Published in Molecular cancer therapeutics (01-09-2006)“…Real-time analysis of gene expression in experimental tumor models represents a major tool to document disease biology and evaluate disease treatment. However,…”
Get full text
Journal Article -
14
Design and Selection of Antisense Oligonucleotides Targeting Transforming Growth Factor Beta (TGF-β) Isoform mRNAs for the Treatment of Solid Tumors
Published in Methods in molecular biology (Clifton, N.J.) (2015)“…Transforming growth factor beta isoforms (TGF-β1, -β2, and -β3) are cytokines associated with a wide range of biological processes in oncology including tumor…”
Get more information
Journal Article -
15
p53-Independent Regulation of p21Waf1/Cip1 Expression and Senescence by Chk2
Published in Molecular cancer research (01-11-2005)“…The Chk2 kinase is a tumor suppressor and key component of the DNA damage checkpoint response that encompasses cell cycle arrest, apoptosis, and DNA repair. It…”
Get full text
Journal Article -
16
R176502, a new bafilolide metabolite with potent antiproliferative activity from a novel Micromonospora species
Published in Journal of antibiotics (01-11-2003)“…During the course of a screening program intended to identify new antiproliferative agents, a new bafilolide metabolite was discovered. R176502 (1) was…”
Get more information
Journal Article -
17
TGF-β2 silencing to target biliary-derived liver diseases
Published in Gut (01-09-2020)“…TGF-β2 (TGF-β, transforming growth factor beta), the less-investigated sibling of TGF-β1, is deregulated in rodent and human liver diseases. Former data from…”
Get more information
Journal Article -
18
Hyperthermia enhances the effects of chemotherapeutic agents on pancreatic cancer cell proliferation and survival
Published in European journal of surgical oncology (01-02-2022)Get full text
Journal Article -
19
Phase I/Ib study with INT-1B3, a novel LNP-formulated micro-RNA (miR-193a-3p mimic) therapeutic for patients with advanced solid cancer
Published in Journal of clinical oncology (20-05-2021)“…Abstract only TPS2666 Background: MicroRNAs (miR) are naturally-occurring small non-coding RNA molecules involved in the regulation of gene expression and…”
Get full text
Journal Article -
20
Targeting the WT1mut-Mir-193a Transcriptional Axis with INT-1B3, a Novel Lipid Nanoparticle-Formulated Mir-193a-3p Mimic in Acute Myeloid Leukemia
Published in Blood (15-11-2022)Get full text
Journal Article